Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to IMS Health Incorporated published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 42
» View wsbtradio.com items only
    May 15, 2013 |Story| Reuters
  1. New cancer tools allow patients to reconsider chemo

    LOS ANGELES (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh treatments.
    Reuters
    LOS ANGELES (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh treatments. An approach to oncology that has been in place...

    Tags: Roche Holding AG, Mastectomy, Biotechnology, Lymphoma, Heart Problems

  2. May 6, 2013 |Story| Reuters
  3. REUTERS SUMMIT-Teva better suited than most for China market -CEO

    Reuters
    (For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Bill Berkrot NEW YORK, May 6 (Reuters) - Teva Pharmaceutical Industries Ltd has yet to make any serious inroads into China, but its chief executive...

    Tags: Procter & Gamble, AstraZeneca Plc, Israel, China, Corporate Officers

  4. Apr 24, 2013 |Story| Chicago Tribune
  5. Questions remain after judge lifts age limit on Plan B

    With a federal judge clearing away age restrictions on purchasing emergency contraception, many Chicago-area health care providers, teens and others are preparing for more accessibility — even if they're not exactly sure how the drug will be made available.
    With a federal judge clearing away age restrictions on purchasing emergency contraception, many Chicago-area health care providers, teens and others are preparing for more accessibility — even if they're not exactly sure how the drug will be made...

    Tags: Medical Procedures and Tests, Justice System, Health and Medical Professionals, Judges, Family Planning

  6. Apr 26, 2013 |Story| Reuters
  7. Actavis settles OxyContin lawsuit with Purdue

    Reuters
    April 26 (Reuters) - Generic drugmaker Actavis Inc said it had settled a patent lawsuit with Purdue Pharma related to Actavis' generic version of the abuse-deterrent formulation of Purdue's painkiller OxyContin. Under the agreement, Actavis will be...

    Tags: Drugs and Medicines, Justice System, Watson Pharmaceuticals Incorporated, Crime, Law and Justice, New Products

  8. Apr 5, 2013 |Story| Reuters
  9. U.S. judge widens 'morning-after' pill access for young girls

    Reuters
    NEW YORK (Reuters) - A federal judge on Friday ordered the U.S. Food and Drug Administration to make "morning-after" emergency contraception pills available without a prescription to all girls of reproductive age and criticized the Obama administration...

    Tags: Abortion, University of Florida, Health and Medical Professionals, Roman Catholicism, Elections

  10. Feb 28, 2012 |Story| Los Angeles Times
  11. Sleeping pills linked to higher risk of cancer, death, study says

    A new study suggests that the 6% to 10% of Americans who use prescription sleep medications such as zolpidem (Ambien), temazepam (Restoril), eszopiclone (Lunesta) and zaleplon (Sonata) are more likely to develop cancer, and far more likely to die...

    Tags: Culture, Cancer, Lunesta (drug), Arts and Culture, Health

  12. Jan 10, 2012 |Story| Los Angeles Times
  13. |Story
  14. Feb 2, 2012 |Story| South Florida Sun-Sentinel
  15. |Story
  16. Dec 6, 2011 |Story| Petoskey News
  17. FDA favors more risk information on birth control pills

    WASHINGTON (AP) -- Federal health regulators are leaning toward adding new information about the risk of blood clots to the labels of widely prescribed birth control pills such as Yaz, in light of growing evidence suggesting the newer contraceptive...

    Tags: Yasmin (drug), Hormones and Metabolism, Pregnancy and Childbirth, Mood Disorders, Health

  18. Nov 29, 2011 | Allentown Morning Call
  19. The Big One is going generic

    Health
    The nation's largest-selling pharmaceutical is going generic this week. Lipitor, which is prescribed to help people reduce their cholesterol levels, is going "off-patent" Wednesday. According to a HealthDay News report, Lipitor sales were nearly $4...
  20. Jul 13, 2011 |Story| Jessamine Journal
  21. Supreme Court has been ruling that free speech should indeed be free

    Guest columnist
    The U.S. Supreme Court has given us two terms of remarkable support for free expression — in cases remarkable for speech that many, if not most, of us really, really dislike. And its ruling June 27 that the states cannot forbid the sale or rental of...

    Tags: Government, Elections, Human Rights, California, Local Government

  22. Jul 24, 2011 |Story| Aberdeen News
  23. Prescription drug costs to plummet in wave of expiring patents

    The cost of prescription medicines used by millions of people every day is about to plummet.   The next 14 months will bring generic versions of seven of the world’s 20 best-selling drugs, including the top two: cholesterol fighter Lipitor and...

    Tags: Prescription Drugs, Insulin, Plavix (drug), New York, Physical Conditions

 1  2 3 4Next >
Original site for IMS Health Incorporated topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
IMS Health Incorporated Photos
's life sciences practice as managing director. Linver...
(May 13, 2011)
Mark Linver, managing director, Huron Consulting Group LIfe Sciences